Synaptogenix, Inc.
SNPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | – | 100% | – | 50% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $2 | $1 | $2 |
| SG&A Expenses | $2 | $2 | $1 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1 | $0 | -$0 |
| Operating Expenses | $2 | $3 | $1 | $2 |
| Operating Income | -$2 | -$3 | -$1 | -$2 |
| % Margin | – | -76,623.8% | – | -40,106.8% |
| Other Income/Exp. Net | -$2 | -$14 | $1 | -$3 |
| Pre-Tax Income | -$4 | -$18 | $0 | -$6 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$18 | $0 | -$6 |
| % Margin | – | -442,101.9% | – | -102,108.4% |
| EPS | -1.56 | -11.26 | 0.12 | -4.58 |
| % Growth | 86.1% | -9,483.3% | 102.6% | – |
| EPS Diluted | -1.56 | -11.26 | 0.12 | -4.58 |
| Weighted Avg Shares Out | 3 | 2 | 1 | 1 |
| Weighted Avg Shares Out Dil | 3 | 2 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$2 | $0 | -$2 |
| % Margin | – | -58,935.1% | – | -40,085.2% |